| 
Margaret Gradison, MD, MHS-CL
Associate Professor
Medical Director
BS Brown University, 1976
MD University of Cincinnati, 1981
Internship and Residency in Family Medicine, University of Colorado Health Sciences Center, 1981-84
MHS-CL Duke University, 2006
Dr. Gradison became the Medical Director of the Physician Assistant Program in July 2007. Prior to that she held a number of leadership roles at Duke including Chief of the Division of Family Medicine, Family Medicine Residency Program Director, and Education Director of Duke University Affiliated Physicians. While at Duke she has seen patients in a variety of settings including Duke Diet and Fitness Center, Student Health, and Integrative Medicine, as well as Duke University Affiliated Physicians and Family Medicine. She has had a broad range of teaching experience with medical, nurse practitioner, pharmacy, and physician assistant students, as well as residents and faculty.
Before joining Duke in 1994, Dr. Gradison was on the faculty at University of Colorado and then Indiana University. She began her career in private practice in Colorado in which she worked with a Duke trained Physician Assistant.
Dr. Gradison has lectured nationally and internationally on a variety of clinical and educational topics. Her interests include women’s health, particularly cervical dysplasia and menopausal issues. She is also concerned with health care access and disparities, and issues related to the primary care workforce. In addition, she has been focusing on disease prevention, chronic disease management, and helping patients to improve their lifestyle/health habits. She is also interested in professionalism and integrative medicine. Dr. Gradison is currently a Bravewell Fellow in Integrative Medicine at the University of Arizona in Tucson.
She has a number of publications in different areas including women’s health, residency education, stroke prevention, primary care, and models of care. Examples of her current research projects include use of a traditional Chinese medicine in end stage cancer patients, cervical dysplasia and HPV mutations, and patients’ self perception of health risk factors.
|
